|
AMN Healthcare Services, Inc. (AMN): BCG Matrix [Dec-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
AMN Healthcare Services, Inc. (AMN) Bundle
You're digging into AMN Healthcare Services, Inc.'s (AMN) current health, and the BCG Matrix cuts right to the chase: where's the money coming from, and where should we place our bets for 2026? Honestly, the core business, like Nurse and Allied Solutions, is still pumping out the cash-a $361 million Q3 revenue Cash Cow-funding growth in Stars like Labor Disruption Staffing, which has $100 million in Q4 guidance. But you can't ignore the drag; VMS Revenue is a clear Dog, down 32% to just $17 million, and big potential plays like International Assignments are stuck as Question Marks due to visa issues. Let's see the full picture on where AMN Healthcare Services, Inc. needs to focus its capital next.
Background of AMN Healthcare Services, Inc. (AMN)
You're looking at AMN Healthcare Services, Inc. (AMN), which stands as the recognized leader and innovator in total talent solutions for healthcare organizations across the United States. Honestly, they are the largest healthcare staffing company in the nation, acting as a crucial intermediary connecting clinicians with facilities needing staff. This company helps healthcare organizations optimize their workforce to manage complexity and improve patient care delivery.
The journey for AMN Healthcare Services, Inc. started way back in 1985 in San Diego, California, where it was first established with an initial focus on travel nurse staffing. Over the decades, the company has evolved significantly, adapting to the dynamic needs of the healthcare landscape through strategic growth and adaptation. It went public on the NYSE, which provided the capital needed to expand its offerings substantially over time.
AMN Healthcare Services, Inc. offers a comprehensive suite of services that go beyond simple placement. Their total talent solutions include managed services programs (MSP), vendor management systems (VMS), recruitment process outsourcing (RPO), language services, and technology solutions. Operationally, the business is generally broken down into key segments, including Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.
Looking at the most recent figures as of late 2025, the company reported a consolidated revenue of $634 million for the third quarter ending September 30, 2025. For that same quarter, the GAAP diluted income per share came in at $0.76, while the adjusted diluted EPS was $0.39. To give you a broader view, the trailing twelve-month revenue as of September 30, 2025, was $2.72B. At the end of Q3 2025, cash and cash equivalents on hand totaled $53 million.
AMN Healthcare Services, Inc. (AMN) - BCG Matrix: Stars
You're looking at the units within AMN Healthcare Services, Inc. (AMN) that are currently dominating high-growth areas, meaning they demand significant capital to maintain that leadership position. These are the businesses where market share is high, but the market itself is still expanding rapidly, so we have to keep pouring money in for promotion and placement.
For AMN Healthcare Services, Inc. (AMN) as of late 2025, the Star quadrant is heavily influenced by specialized, high-demand staffing solutions, particularly those tied to ongoing labor volatility. If these units can sustain their success as the overall market growth rate eventually moderates, they are the ones that will mature into the reliable Cash Cows of tomorrow. Our strategy here is clear: invest heavily in these Stars.
Here's a look at the key components fitting the Star profile, based on recent performance and forward guidance:
- Labor Disruption Staffing: High-growth, specialized solution with Q4 2025 guidance projecting approximately $100 million in revenue.
- Allied Staffing: Strong demand and modest 1% year-over-year revenue growth in Q3 2025, positioned for market share gains in a tightening labor market.
- Locum Tenens Staffing: Revenue grew 3% year-over-year in Q3 2025, benefiting from new technology rollouts like AMN Passport.
- Strategic MSP/VMS Wins: New, smaller competitive wins in Managed Service Provider (MSP) contracts, requiring investment to scale into a larger market share.
To give you a clearer picture of the scale and recent momentum of these key areas, look at the Q3 2025 segment results that underpin this Star classification:
| Business Unit/Metric | Q3 2025 Revenue (Millions USD) | Year-over-Year Growth | Key Context |
| Labor Disruption Revenue (Q3 Contrib.) | $12 million | N/A (New/Volatile Driver) | Significant driver for Q4 guidance. |
| Allied Staffing Revenue (Segment Sub-component) | Implied from Nurse & Allied total | 1% | Modest growth in a tightening market. |
| Locum Tenens Revenue (Segment Sub-component) | $146 million | 3% | Benefiting from technology adoption. |
| Nurse and Allied Solutions (Total Segment) | $361.5 million | -9.5% | Overall segment impacted by travel nurse decline, but labor disruption is a key growth pocket. |
The Labor Disruption Staffing component is definitely the purest Star right now; management is projecting about $100 million in revenue from this specific activity in the fourth quarter of 2025. That kind of concentrated, high-velocity revenue stream in a volatile environment screams Star, but it also means the associated selling, general, and administrative (SG&A) expenses are elevated, with about $5 million in extra costs expected in Q4 just to support this activity. Here's the quick math: high revenue contribution from a specialized area, but high support costs mean cash flow neutrality, which is classic Star behavior.
For the other units, like Locum Tenens Staffing, the 3% year-over-year revenue growth to $146 million in Q3 shows solid, albeit slower, market leadership. Allied Staffing, showing 1% growth in Q3, is holding its ground while the broader Nurse and Allied Solutions segment saw a 9.5% decline overall. This suggests Allied is gaining share within its sub-market, which is what we want to see in a Star candidate.
The Strategic MSP/VMS Wins area is where the investment thesis is most pronounced. While the Technology and Workforce Solutions segment saw revenue decline by 12% year-over-year in Q3, securing new, smaller MSP contracts represents an investment in future market share. We are spending now to scale these wins, hoping they transition from Question Marks or Dogs into future Stars, and eventually Cash Cows, once the market matures or our investment pays off.
Finance: draft 13-week cash view by Friday.
AMN Healthcare Services, Inc. (AMN) - BCG Matrix: Cash Cows
Cash Cows for AMN Healthcare Services, Inc. (AMN) are those business units operating in mature, lower-growth segments where the company maintains a commanding market share, allowing them to generate significant free cash flow that supports the entire enterprise.
The Nurse and Allied Solutions segment is the primary engine here, representing the largest portion of the business and providing the core cash flow. For the third quarter of 2025, this segment posted revenue of $361 million. This cash generation is vital, even as the segment navigates market shifts.
Within that core segment, Core Travel Nurse Staffing remains a substantial component, though it faced headwinds. Travel nurse staffing revenue for Q3 2025 was lower by 20% year-over-year. Still, this unit's sheer scale means it generates substantial revenue to fund other ventures, including those in higher-growth, more uncertain areas of the portfolio.
Also fitting the Cash Cow profile is the Language Services business. This is characterized as a stable, high-margin operation, reporting Q3 2025 revenue of $75 million. While management noted pricing pressure, its established position helps maintain strong margins and consistent cash contribution.
The overall financial health supporting this category is evident in the consolidated profitability. For Q3 2025, the High Adjusted EBITDA Margin demonstrated strong cash generation from these core operations, with Consolidated Adjusted EBITDA reported at $57.5 million.
You can see the revenue contribution from these key areas in the table below:
| Segment/Component | Q3 2025 Revenue (Millions USD) | Year-over-Year Change |
| Consolidated Revenue | $634.5 | -8% |
| Nurse and Allied Solutions (Total) | $361 | -9% |
| Core Travel Nurse Staffing | $196 | -20% |
| Allied Staffing | $142 | +1% |
| Language Services | $75 | Flat |
These cash cows are essential because they fund the rest of the AMN Healthcare Services, Inc. portfolio. Here's what these units are doing:
- Maintain market leadership in mature staffing verticals.
- Generate the necessary cash to cover corporate overhead.
- Fund investments into Question Mark business units.
- Provide a buffer against volatility in other segments.
- Support infrastructure improvements to drive efficiency.
The focus for these units is maintaining the current level of productivity, or what we call 'milking the gains passively.' For instance, the Nurse and Allied Solutions segment's operating margin improved slightly to 8.0% in Q3 2025 from 7.5% in the prior quarter, showing management is focused on operational efficiency even with volume declines.
Finance: draft 13-week cash view by Friday.
AMN Healthcare Services, Inc. (AMN) - BCG Matrix: Dogs
You're looking at the parts of AMN Healthcare Services, Inc. (AMN) that are stuck in low-growth markets with minimal market penetration. These are the units that tie up capital without offering much return, making divestiture a strong consideration.
The Technology and Workforce Solutions segment houses some of these laggards. Specifically, the Vendor Management Systems (VMS) business is showing real contraction, which you can see clearly when you map it against the prior year's performance.
| Metric | Q3 2025 Value | Year-over-Year Change | Q3 2024 Value |
| Vendor Management Systems (VMS) Revenue | $17 million | Down 32% | $25 million |
That $17 million in VMS revenue for the third quarter of 2025 represents a significant drop, down 32% from the $25 million reported in the third quarter of 2024. Honestly, expensive turn-around plans rarely work here; the market dynamics just aren't favorable for this specific offering right now.
Moving into the Physician and Leadership Solutions area, we see similar pressure on specific, high-cost staffing niches. Interim Leadership Staffing revenue is definitely showing weakness, reflecting a volatile market for those temporary executive roles.
- Interim Leadership Staffing Revenue declined 20% year-over-year in Q3 2025.
Also within that segment, the Physician and Leadership Search business is a smaller, contracting line. It's not consuming huge amounts of cash, but it certainly isn't generating much either, making it a classic cash trap candidate.
- Physician and Leadership Search Revenue declined 7% year-over-year in Q3 2025.
- The overall Physician and Leadership Solutions segment revenue was $178.21 million in Q3 2025, a year-over-year change of only -1.3%.
These units fit the Dog profile perfectly: low market share and low growth rates. You're looking at units that frequently break even, neither earning nor consuming much cash, but still requiring management attention that could be better spent elsewhere.
AMN Healthcare Services, Inc. (AMN) - BCG Matrix: Question Marks
You're looking at the business units within AMN Healthcare Services, Inc. (AMN) that are in high-growth markets but haven't yet secured a dominant position. These are the Question Marks, consuming cash now with the hope they mature into Stars. They require heavy investment to capture more market, or they risk becoming Dogs.
Here is the current status of the key areas fitting this profile as of the third quarter of 2025.
Technology and Workforce Solutions (Post-Divestiture)
This segment is facing immediate pressure, yet the underlying market for healthcare technology remains dynamic. Segment revenue declined 11.8% in Q3 2025, as stated in the outline, though the reported year-over-year decline was 12% to $95 million in Q3 2025. This followed a 7% sequential revenue drop. The segment's operating margin was 32.6% in Q3 2025, a step down from 39.0% in Q3 2024. The company projects this segment revenue to be down 14-16% year-over-year in the fourth quarter of 2025. The divestiture of Smart Square software contributed to the sequential revenue decrease.
The segment's components show varied performance:
| Component | Q3 2025 Revenue (Millions USD) | Year-over-Year Change | Sequential Change |
| Technology & Workforce Solutions (Total) | $95 | -12% | -7% |
| Vendor Management Systems (VMS) | $17 | -32% | -11% |
| Language Services | $75 | 0% (Flat) | -1% |
The VMS portion, specifically, saw its revenue fall 32% year-over-year to $17 million. You need to watch the capital allocation here; these units are burning cash relative to their current market share.
International Nurse Assignments
This area is positioned for future growth, but near-term execution is hampered by external factors. The business faces significant headwinds from visa retrogression, which is causing expected delays in clinician deployment. This uncertainty is causing an expected revenue reduction in 2025, forcing clients to rely more on domestic temporary labor. However, management has signaled a strong turnaround, projecting >20% revenue growth for International Nurse assignments in 2026, which is noted as a higher-margin business.
The strategy here involves managing the current pipeline through the visa backlog:
- Control what you can control: encourage early petition filing.
- Leverage the time delay to build a full pipeline for 2026 and 2027.
- Focus on the temp-to-perm model for long-term security.
ShiftWise Flex Platform
ShiftWise Flex is AMN Healthcare Services, Inc.'s next-generation Vendor Management System (VMS), designed to manage the total talent needs of healthcare organizations. It has been named a 'Major Contender' by Everest Group in their VMS PEAK Matrix Assessment. The platform was recently enhanced with Market Insights, a feature providing daily updates on bill rate pricing and market datasets across all 50 U.S. States and DC. This tool is key to driving adoption by offering transparent, data-driven decision-making for clients.
The challenge is converting this technological investment into measurable market share gains and revenue contribution that outpaces the segment's overall decline. The platform's success is still developing and requires further capital investment to scale its adoption against established competitors.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.